Pettee Investors, Inc. Viatris Inc Call Options Transaction History
Pettee Investors, Inc.
- $162 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding VTRS
# of Institutions
1,123Shares Held
965MCall Options Held
4.73MPut Options Held
2.99M-
Vanguard Group Inc Valley Forge, PA145MShares$1.47 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$938 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD74.5MShares$754 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az66.4MShares$672 Million3.26% of portfolio
-
State Street Corp Boston, MA61.5MShares$622 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.3B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...